Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 4B (HCG4B) is a long non-coding RNA gene located in the human major histocompatibility complex (MHC) region and is annotated as a pseudogene[4][5]. It does not encode a functional receptor or protein and is not a recognized therapeutic target. The locus is distinct from protein-coding HLA genes (such as HLA-B) that play important roles in immune response and disease, and confusion with those targets should be avoided[2][3]. HCG4B may have minor or uncharacterized roles in gene regulation within the MHC region, but no definitive biological or disease role has been established. It is identified primarily by sequence and genomics databases and has several alternate names, most relating to its pseudogene status or genomic location. Key considerations: - HCG4B is non-protein coding and not a classical molecular target. - No drugs or biomarkers are associated with HCG4B. - It is sometimes misclassified as a functional HLA gene due to naming similarity; confirm functional context when extracting data. - Use care not to conflate HCG4B with true therapeutic MHC class I or II HLA proteins (e.g., HLA-B)[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 4B pseudogene (HCG4B).